Study Finds Many New Cancer Drugs Show Limited Success
A new study found that many cancer drugs receiving accelerated government approval do not show good results. It suggests 41 percent of cancer drugs given accelerated approval do not improve or extend patients’ lives within five years. Forty-three percent showed good results.